These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 2234330)

  • 41. Boron neutron capture therapy (BNCT) inhibits tumor development from precancerous tissue: an experimental study that supports a potential new application of BNCT.
    Monti Hughes A; Heber EM; Pozzi E; Nigg DW; Calzetta O; Blaumann H; Longhino J; Nievas SI; Aromando RF; Itoiz ME; Trivillin VA; Schwint AE
    Appl Radiat Isot; 2009 Jul; 67(7-8 Suppl):S313-7. PubMed ID: 19376711
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Boron neutron capture therapy: cellular targeting of high linear energy transfer radiation.
    Coderre JA; Turcotte JC; Riley KJ; Binns PJ; Harling OK; Kiger WS
    Technol Cancer Res Treat; 2003 Oct; 2(5):355-75. PubMed ID: 14529302
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Performance of sulfhydryl boron hydride in patients with grade III and IV astrocytoma: a basis for boron neutron capture therapy.
    Ceberg CP; Persson A; Brun A; Huiskamp R; Fyhr AS; Persson BR; Salford LG
    J Neurosurg; 1995 Jul; 83(1):79-85. PubMed ID: 7782854
    [TBL] [Abstract][Full Text] [Related]  

  • 44. EGF-receptor targeted liposomes with boronated acridine: growth inhibition of cultured glioma cells after neutron irradiation.
    Kullberg EB; Wei Q; Capala J; Giusti V; Malmström PU; Gedda L
    Int J Radiat Biol; 2005 Aug; 81(8):621-9. PubMed ID: 16298943
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Identification of early and distinct glioblastoma response patterns treated by boron neutron capture therapy not predicted by standard radiographic assessment using functional diffusion map.
    Hiramatsu R; Kawabata S; Furuse M; Miyatake S; Kuroiwa T
    Radiat Oncol; 2013 Aug; 8(1):192. PubMed ID: 23915330
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Translational research of boron neutron capture therapy for spinal cord gliomas using rat model.
    Kayama R; Tsujino K; Kawabata S; Fujikawa Y; Kashiwagi H; Fukuo Y; Hiramatsu R; Takata T; Tanaka H; Suzuki M; Hu N; Miyatake SI; Takami T; Wanibuchi M
    Sci Rep; 2024 Apr; 14(1):8265. PubMed ID: 38594281
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Molecular targeting and treatment of EGFRvIII-positive gliomas using boronated monoclonal antibody L8A4.
    Yang W; Barth RF; Wu G; Kawabata S; Sferra TJ; Bandyopadhyaya AK; Tjarks W; Ferketich AK; Moeschberger ML; Binns PJ; Riley KJ; Coderre JA; Ciesielski MJ; Fenstermaker RA; Wikstrand CJ
    Clin Cancer Res; 2006 Jun; 12(12):3792-802. PubMed ID: 16778107
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Perspectives of the clinical BNCT of malignant gliomas in Czechoslovakia.
    Sourek K; Tovarys F
    Strahlenther Onkol; 1989; 165(2-3):247-9. PubMed ID: 2494741
    [No Abstract]   [Full Text] [Related]  

  • 49. Hydroxylforms of p-boronophenylalanine as potential boron carriers on boron neutron capture therapy for malignant brain tumors.
    Takagaki M; Ono K; Oda Y; Kikuchi H; Nemoto H; Iwamoto S; Cai J; Yamamoto Y
    Cancer Res; 1996 May; 56(9):2017-20. PubMed ID: 8616843
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Pharmacokinetics and boron uptake of BSH (Na2B12H11SH) in patients with intracranial tumors.
    Kageji T; Nakagawa Y; Kitamura K; Matsumoto K; Hatanaka H
    J Neurooncol; 1997 May; 33(1-2):117-30. PubMed ID: 9151229
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Pharmacokinetic study of BSH and BPA in simultaneous use for BNCT.
    Yokoyama K; Miyatake S; Kajimoto Y; Kawabata S; Doi A; Yoshida T; Asano T; Kirihata M; Ono K; Kuroiwa T
    J Neurooncol; 2006 Jul; 78(3):227-32. PubMed ID: 16557351
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Applicability of the 2-nitroimidazole-sodium borocaptate-10B conjugate, TX-2060, as a 10B-carrier in boron neutron capture therapy.
    Masunaga S; Nagasawa H; Hiraoka M; Sakurai Y; Uto Y; Hori H; Nagata K; Suzuki M; Maruhashi A; Kinashi Y; Ono K
    Anticancer Res; 2004; 24(5A):2975-83. PubMed ID: 15517904
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Boron neutron capture therapy induces cell cycle arrest and cell apoptosis of glioma stem/progenitor cells in vitro.
    Sun T; Zhang Z; Li B; Chen G; Xie X; Wei Y; Wu J; Zhou Y; Du Z
    Radiat Oncol; 2013 Aug; 8(1):195. PubMed ID: 23915425
    [TBL] [Abstract][Full Text] [Related]  

  • 54. In vitro and in vivo evaluation of carboranyl uridines as boron delivery agents for neutron capture therapy.
    Liu L; Barth RF; Tjarks W; Soloway AH; Anisuzzaman AK
    Anticancer Res; 1996; 16(1):113-20. PubMed ID: 8615595
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Application of boron-entrapped stealth liposomes to inhibition of growth of tumour cells in the in vivo boron neutron-capture therapy model.
    Yanagie H; Maruyama K; Takizawa T; Ishida O; Ogura K; Matsumoto T; Sakurai Y; Kobayashi T; Shinohara A; Rant J; Skvarc J; Ilic R; Kuhne G; Chiba M; Furuya Y; Sugiyama H; Hisa T; Ono K; Kobayashi H; Eriguchi M
    Biomed Pharmacother; 2006 Jan; 60(1):43-50. PubMed ID: 16260113
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Binding and distribution of Na2B12H11SH on cellular and subcellular level in tumor tissue of glioma patients in boron neutron capture therapy.
    Otersen B; Haritz D; Grochulla F; Bergmann M; Sierralta W; Gabel D
    J Neurooncol; 1997 May; 33(1-2):131-9. PubMed ID: 9151230
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Delivery of (10)boron to oral squamous cell carcinoma using boronophenylalanine and borocaptate sodium for boron neutron capture therapy.
    Obayashi S; Kato I; Ono K; Masunaga S; Suzuki M; Nagata K; Sakurai Y; Yura Y
    Oral Oncol; 2004 May; 40(5):474-82. PubMed ID: 15006618
    [TBL] [Abstract][Full Text] [Related]  

  • 58. The role of boron MRI in boron neutron capture therapy.
    Kabalka GW; Tang C; Bendel P
    J Neurooncol; 1997 May; 33(1-2):153-61. PubMed ID: 9151232
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Boron neutron capture therapy of the rat 9L gliosarcoma: evaluation of the effects of shark cartilage.
    Morris GM; Coderre JA; Micca PL; Lombardo DT; Hopewell JW
    Br J Radiol; 2000 Apr; 73(868):429-34. PubMed ID: 10844870
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Quantitative imaging of a radiotherapeutic drug, Na2B12H11SH, at subcellular resolution in tissue cultures using ion microscopy.
    Zha X; Ausserer WA; Morrison GH
    Cancer Res; 1992 Oct; 52(19):5219-22. PubMed ID: 1394124
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.